Medication info
Pregabalin 150 mg Capsule

Pregabalin 150 mg Capsule

Prescription medicationHard capsuleOral
Ingredient · strength
Pregabalin›150mg / 1 capsule
Manufacturer / importer
Dongbang FTL Co., Ltd.
Appearance
A white hard capsule with the upper part white and the lower part white containing a white powder that is white or pale yellow.
Packaging
30 capsules/bottle, 100 capsules/bottle
Approval status
Active

MFDS item code 201801211 · Approved 2018.03.20 · Insurance code 680500720

Summary

Main use
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures in epilepsy
Who takes it
Adults · Children
Adult dose
This medicine is administered orally as pregabalin in two divided doses per day, regardless of food. Because this medicine is eliminated primarily by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with Renal Impairment’.) 1. Neuropathic Pain 1) Peripheral Neuropathic Pain Adults: The recommended starting dose is 150 mg/day. Based on individual patient response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg/day. 2) Central Neuropathic Pain Adults: The recommended starting dose is 150 mg/day. Based on individual patient response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional 1 week, it may be increased to the target dose of 600 mg/day. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation of Treatment’.) 2. Epilepsy Adults: The recommended starting dose is 150 mg/day. Based on individual patient response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg to 450 mg/day. The starting dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies have also been conducted at a dose of 600 mg/day; however, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation of Treatment Based on current clinical experience, when discontinuing this medicine, it should be withdrawn gradually over a period of at least 1 week. 5. Patients with Renal Impairment After entering the systemic circulation, this medicine is eliminated primarily by the kidneys as unchanged drug. Because the clearance of this medicine is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function Creatinine clearance (CLcr), (mL/min) Total daily dose of pregabalin a Dosage regimen Starting dose (mg/day) Maximum dose (mg/day) ≥60: starting dose 150 mg/day, maximum dose 600 mg/day, BID or TID ≥30 -<60: starting dose 75 mg/day, maximum dose 300 mg/day, BID or TID ≥15 -<30: starting dose 25-50 mg/day, maximum dose 150 mg/day, QD or BID <15: starting dose 25 mg/day, maximum dose 75 mg/day, QD Supplemental dose after hemodialysis: 25 mg, 100 mg, single dose b TID = total daily dose administered in 3 divided doses BID = total daily dose administered in 2 divided doses QD = administered once daily a: The total daily dose (mg/day) should be administered in divided doses as specified in the dosage regimen. b: The supplemental dose refers to an additional dose administered as a single dose. 6. Patients with Hepatic Impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Older Adults (65 years and older) Dose reduction may be necessary in older adults with impaired renal function.
Child dose
Since there are insufficient safety and efficacy data for children under 12 years of age and adolescent patients aged 12~17 years, administration is not recommended.

Ingredients

Manufacturer
Dongbang FTL Co., Ltd.

Efficacy & effects

Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures in epilepsy

  • Peripheral neuropathic pain
  • central neuropathic pain
  • partial seizures
  • fibromyalgia.
View approved original text

This medication is used to treat peripheral and central neuropathic pain in adults. Additionally, it serves as an adjunct for partial seizures in patients with epilepsy, applicable in both cases with or without secondary generalized symptoms. It is also helpful in the treatment of fibromyalgia. In summary, this medication is used for the relief of neuropathic pain, adjunctive treatment of partial seizures in epilepsy, and treatment of fibromyalgia.

How to take

Adult dose

This medicine is administered orally as pregabalin in two divided doses per day, regardless of food. Because this medicine is eliminated primarily by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with Renal Impairment’.) 1. Neuropathic Pain 1) Peripheral Neuropathic Pain Adults: The recommended starting dose is 150 mg/day. Based on individual patient response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg/day. 2) Central Neuropathic Pain Adults: The recommended starting dose is 150 mg/day. Based on individual patient response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional 1 week, it may be increased to the target dose of 600 mg/day. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation of Treatment’.) 2. Epilepsy Adults: The recommended starting dose is 150 mg/day. Based on individual patient response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg to 450 mg/day. The starting dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies have also been conducted at a dose of 600 mg/day; however, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation of Treatment Based on current clinical experience, when discontinuing this medicine, it should be withdrawn gradually over a period of at least 1 week. 5. Patients with Renal Impairment After entering the systemic circulation, this medicine is eliminated primarily by the kidneys as unchanged drug. Because the clearance of this medicine is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function Creatinine clearance (CLcr), (mL/min) Total daily dose of pregabalin a Dosage regimen Starting dose (mg/day) Maximum dose (mg/day) ≥60: starting dose 150 mg/day, maximum dose 600 mg/day, BID or TID ≥30 -<60: starting dose 75 mg/day, maximum dose 300 mg/day, BID or TID ≥15 -<30: starting dose 25-50 mg/day, maximum dose 150 mg/day, QD or BID <15: starting dose 25 mg/day, maximum dose 75 mg/day, QD Supplemental dose after hemodialysis: 25 mg, 100 mg, single dose b TID = total daily dose administered in 3 divided doses BID = total daily dose administered in 2 divided doses QD = administered once daily a: The total daily dose (mg/day) should be administered in divided doses as specified in the dosage regimen. b: The supplemental dose refers to an additional dose administered as a single dose. 6. Patients with Hepatic Impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Older Adults (65 years and older) Dose reduction may be necessary in older adults with impaired renal function.

Child dose

Since there are insufficient safety and efficacy data for children under 12 years of age and adolescent patients aged 12~17 years, administration is not recommended.

Precautions

This medication may increase the risk of suicidal thoughts or behaviors; therefore, if symptoms of depression or mood changes occur during use, one should consult a doctor immediately. Patients with hypersensitivity to this medication or with genetic issues such as lactose intolerance should not take it. Diabetic patients should be cautious as adjustments to blood glucose control medications may be necessary due to potential weight gain. If symptoms of angioedema occur, discontinue this medication immediately and inform healthcare professionals. Elderly patients should exercise caution, particularly at the start of treatment, due to the risk of dizziness or drowsiness leading to falls. If experiencing blurred vision or changes in eyesight, consult a doctor. Sudden discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so it should be tapered off gradually under a doctor's guidance. Patients with a history of substance abuse should take this medication with caution due to the potential risk of misuse. Patients with impaired renal function may require dose adjustments. Patients with heart conditions should use this medication with care. When taken with opioid analgesics, there is an increased risk of central nervous system depression, so caution should be exercised. This medication may cause drowsiness and dizziness; thus activities such as driving or operating hazardous machinery should only be performed after confirming one’s symptoms. During early pregnancy, there may be an increased risk of fetal malformations, so use during pregnancy is not recommended, and women of childbearing age should employ effective contraception. While breastfeeding, as this medication can be passed into breast milk, discussions with a doctor regarding either stopping breastfeeding or discontinuing the medication are advised. In cases of overdose, severe drowsiness, confusion, and seizures may occur, necessitating immediate medical attention and potentially blood dialysis treatment. Keep out of reach of children, and do not transfer to other containers as a precaution. This medication may have various side effects; therefore, any new symptoms or abnormal reactions should be reported to healthcare professionals immediately.

Side effects

  • suicidal ideation
  • suicidal behavior
  • depression
  • abnormal mood and behavior changes
  • angioedema
  • facial swelling
  • swelling around the mouth
  • upper airway swelling
  • dizziness
  • drowsiness
Show 180 more
  • loss of consciousness
  • confusion
  • mental disorders
  • blurred vision
  • changes in vision
  • insomnia
  • headache
  • nausea
  • anxiety
  • diarrhea
  • influenza-like illness
  • restlessness
  • depression
  • suicidal thoughts
  • pain
  • seizures
  • hyperhidrosis
  • misuse
  • abuse
  • dependence
  • weight gain
  • rhinitis
  • neutropenia
  • increased appetite
  • decreased appetite
  • hypoglycemia
  • confusion
  • spatial disorientation
  • irritability
  • euphoria
  • decreased libido
  • depersonalization
  • sexual dysfunction
  • agitation
  • mood swings
  • emotional blunting
  • emotional elevation
  • hallucination
  • abnormal dreams
  • increased libido
  • panic attack
  • impulsivity
  • apathy
  • ataxia
  • impaired coordination
  • balance disorder
  • amnesia
  • attention deficit
  • memory impairment
  • tremor
  • speech disturbance
  • sensory abnormalities
  • sensory loss
  • sedation
  • somnolence
  • cognitive impairment
  • nystagmus
  • language disorders
  • myoclonic jerks
  • reflex decrease
  • motor abnormalities
  • psychomotor agitation
  • positional dizziness
  • hypersensitivity
  • burning sensation
  • tremor during activity
  • syncope
  • stupor
  • hypokinesia
  • olfactory disorders
  • taste loss
  • writing difficulty
  • diplopia
  • vertigo
  • auditory hypersensitivity
  • first-degree AV block
  • tachycardia
  • sinus bradycardia
  • sinus tachycardia
  • sinus arrhythmia
  • hypotension
  • hypertension
  • flushing
  • facial flushing
  • peripheral coldness
  • dyspnea
  • epistaxis
  • cough
  • nasal congestion
  • rhinitis
  • snoring
  • throat tension
  • nasal dryness
  • respiratory depression
  • vomiting
  • abdominal distension
  • constipation
  • dry mouth
  • bloating
  • excessive salivation
  • gastroesophageal reflux
  • oral sensory loss
  • ascites
  • dysphagia
  • pancreatitis
  • sweating
  • papular rash
  • urticaria
  • cold sweat
  • muscle cramps
  • arthralgia
  • back pain
  • limb pain
  • cervical spasm
  • joint swelling
  • myalgia
  • muscular cramps
  • neck pain
  • muscle rigidity
  • rhabdomyolysis
  • urinary dysfunction
  • incontinence
  • decreased urination
  • renal failure
  • erectile dysfunction
  • delayed ejaculation
  • sexual dysfunction
  • dysmenorrhea
  • amenorrhea
  • mastalgia
  • breast discharge
  • breast enlargement
  • peripheral edema
  • edema
  • gait disturbances
  • falls
  • feeling intoxicated
  • altered sensation
  • fatigue
  • chest tightness
  • generalized edema
  • pain
  • fever
  • chills
  • weakness
  • thirst
  • weight gain
  • increased alanine aminotransferase
  • increased creatine phosphokinase
  • increased aspartate aminotransferase
  • increased blood sugar
  • decreased platelet count
  • decreased potassium in the blood
  • increased creatinine in the blood
  • decreased white blood cell count
  • hypersensitivity
  • allergic reactions
  • headache
  • keratitis
  • congestive heart failure
  • pulmonary edema
  • tongue swelling
  • itching
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • urinary retention
  • gynecomastia
  • lethargy
  • delirium
  • paralysis (facial paralysis)
  • affective disorder
  • drowsiness
  • confusional state
  • agitation
  • restlessness
  • worsening of convulsions
  • shock
  • anaphylaxis-like symptoms
  • skin and mucosal syndrome
  • erythema multiforme

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture, and it is recommended to keep it in a cool place between 15 to 30 degrees Celsius.

Appearance and packaging

Appearance

A white hard capsule with the upper part white and the lower part white containing a white powder that is white or pale yellow.

Package unit

30 capsules/bottle, 100 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.